These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24949874)

  • 1. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.
    Shan T; Lu H; Ji H; Li Y; Guo J; Chen X; Wu T
    PLoS One; 2014; 9(6):e97239. PubMed ID: 24949874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.
    Witkiewicz AK; Dasgupta A; Sotgia F; Mercier I; Pestell RG; Sabel M; Kleer CG; Brody JR; Lisanti MP
    Am J Pathol; 2009 Jun; 174(6):2023-34. PubMed ID: 19411448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
    Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
    World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
    Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
    Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
    Saeed-Vafa D; Marchion DC; McCarthy SM; Hakam A; Lopez A; Wenham RM; Apte SM; Chen DT; Magliocco AM; Lancaster JM; Reid BM; Permuth JB
    PLoS One; 2021; 16(11):e0256615. PubMed ID: 34813586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
    El-Gendi SM; Mostafa MF; El-Gendi AM
    Pathol Oncol Res; 2012 Apr; 18(2):459-69. PubMed ID: 22057638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.
    Trimmer C; Sotgia F; Whitaker-Menezes D; Balliet RM; Eaton G; Martinez-Outschoorn UE; Pavlides S; Howell A; Iozzo RV; Pestell RG; Scherer PE; Capozza F; Lisanti MP
    Cancer Biol Ther; 2011 Feb; 11(4):383-94. PubMed ID: 21150282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.
    Chatterjee M; Ben-Josef E; Thomas DG; Morgan MA; Zalupski MM; Khan G; Andrew Robinson C; Griffith KA; Chen CS; Ludwig T; Bekaii-Saab T; Chakravarti A; Williams TM
    Sci Rep; 2015 Jun; 5():10867. PubMed ID: 26065715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
    Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
    Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of caveolin in breast cancer: a meta-analysis.
    Ma X; Liu L; Nie W; Li Y; Zhang B; Zhang J; Zhou R
    Breast; 2013 Aug; 22(4):462-9. PubMed ID: 23639584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.
    Witkiewicz AK; Dasgupta A; Nguyen KH; Liu C; Kovatich AJ; Schwartz GF; Pestell RG; Sotgia F; Rui H; Lisanti MP
    Cancer Biol Ther; 2009 Jun; 8(11):1071-9. PubMed ID: 19502809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
    Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
    J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer.
    Zhao X; He Y; Gao J; Fan L; Li Z; Yang G; Chen H
    PLoS One; 2013; 8(3):e59102. PubMed ID: 23527097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.
    Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK
    Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma.
    Tanase CP; Dima S; Mihai M; Raducan E; Nicolescu MI; Albulescu L; Voiculescu B; Dumitrascu T; Cruceru LM; Leabu M; Popescu I; Hinescu ME
    J Mol Histol; 2009 Feb; 40(1):23-9. PubMed ID: 19160064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer.
    He Y; Zhao X; Gao J; Fan L; Yang G; Cho WC; Chen H
    Int J Mol Sci; 2012 Oct; 13(11):13764-80. PubMed ID: 23203033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
    Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
    Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients.
    Qian N; Ueno T; Kawaguchi-Sakita N; Kawashima M; Yoshida N; Mikami Y; Wakasa T; Shintaku M; Tsuyuki S; Inamoto T; Toi M
    Cancer Sci; 2011 Aug; 102(8):1590-6. PubMed ID: 21585620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.